OPKO Health, Inc. (NYSE:OPK) and Bio-Reference Laboratories, Inc.
(NASDAQ:BRLI), today announced that early termination of the waiting
period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976
(the "HSR Act") has been granted, effective July 1, 2015, for OPKO's
planned acquisition of Bio-Reference.
This ... read more